Background & Aims: The hypothesis that cholecystokinin release require
s adequate dietary fat digestion in the small intestine was investigat
ed in 10 healthy volunteers, and the consequences of reduced fat hydro
lysis on pancreaticobiliary secretions were assessed. Methods: Fat hyd
rolysis was inhibited by intraduodenal perfusion of tetrahydrolipstati
n, an irreversible lipase inhibitor. An oil emulsion containing 0, 30,
60, or 120 mg tetrahydrolipstatin was perfused. After a 40-minute bas
al period, a test meal was eaten to stimulate cholecystokinin release
and pancreaticobiliary responses. Results: In the control without tetr
ahydrolipstatin, lipase output increased threefold with meal ingestion
and remained doubled for 4 hours. At the ligament of Treitz, free fat
ty acid concentration averaged 60% of total fatty acids. increasing do
ses of tetrahydrolipstatin induced a dose-dependent inhibition of duod
enal lipase activity (P < 0.01); 120 mg tetrahydrolipstatin eliminated
the postprandial lipase peak activity, free fatty acid levels decreas
ed to <5% of total fatty acids, and plasma cholecystokinin levels were
suppressed by 77% (P < 0.01). Amylase and trypsin outputs were reduce
d by 77% and 59%, respectively, and bilirubin secretion was virtually
abolished (P < 0.01). Conclusions: These findings show that tetrahydro
lipstatin prevents triglyceride hydrolysis and that plasma cholecystok
inin release, gall-bladder emptying, and pancreatic enzyme secretion r
equire adequate triglyceride digestion. These data also support the co
ncept of negative feedback regulation of cholecystokinin secretion.